Radio Compass Blog | Pharmaceutical Articles at Pharmacompass.com

#PharmaFlow

Access
Interactive
Dashboard

Hyaluronic acid – latest developments in a booming market

Hyaluronic acid (HA) is a non-sulfated glycosaminoglycan that is found in almost all connective tissues in mammals. It is found in the highest concentrations in fluids in the eyes and joints. Sodium hyaluronate is the salt form of hyaluronic aci...

2021-07-22

#PharmaFlow by PHARMACOMPASS

#Blog

India reports steep rise in API prices; US$ 26 billion settlement announced to resolve opioid lawsuits

In Phispers this week, we bring you news that a group of state attorneys general in the US has unveiled a landmark US$ 26 billion settlement with major American drug companies that have been accused of fueling the opioid epidemic. The USFDA has g...

2021-07-22

#Phispers by PHARMACOMPASS

#Blog

Phillip Morris acquires two drug firms; Pfizer, WHO remain at loggerheads over booster shots

This week, Phispers brings you lots of news from the US, the world’s largest pharmaceutical market. The US Food and Drug Administration (FDA) had approved Biogen’s Alzheimer’s drug — aducanumab — last month. But now, law...

2021-07-15

#Phispers by PHARMACOMPASS

#Blog

GSK hits back at Elliot, supports CEO; Israel says Pfizer jab only 64% effective against delta variant

This week, Phispers brings you an update on the GSK-Elliot Management saga, as the activist investor issued a 17-page open letter questioning the British company’s performance last week. GSK hit back at Elliot Management by supporting CEO Emma ...

2021-07-08

#Phispers by PHARMACOMPASS

#Blog

Pfizer, CDC differ on need for vaccine booster shots; FDA warning letter to Lupin reveals repeat violations

This week, Phispers brings you news on Intellia’s gene-editing technology that showed improvements in patients with inherited liver disorder. Pfizer Korea halted the circulation of its anti-nicotine therapy due to nitrosamine impurities. W...

2021-07-01

#Phispers by PHARMACOMPASS

#Blog

GSK CEO under pressure, to demerge consumer arm by mid-2022; Biden drops plans to donate Astra vaccine

This week, Phispers brings you updates on GlaxoSmithKline, whose CEO Emma Walmsley announced plans to turn its consumer healthcare arm into a separate listed company, a move that will generate US$ 11 billion for the British drugmaker. In M&...

2021-06-24

#Phispers by PHARMACOMPASS

#Blog

Lupin receives FDA warning letter for Somerset plant; Delta variant may become dominant in US

This week, Phispers has lots of updates on antibody cocktails and the Delta variant of the SARS-CoV-2 virus that causes Covid-19. While a study undertaken by Public Health England has suggested that both the AstraZeneca and the Pfizer vaccines are...

2021-06-17

#Phispers by PHARMACOMPASS

#Blog

Biden announces plan to make crucial drugs in US; FDA gives controversial nod to Biogen’s Alzheimer’s drug

This week, Phispers brings you an update on two degenerative diseases that so far have had no treatment options — Alzheimer’s and Parkinson’s disease. The FDA granted an accelerated approval to Biogen’s controversial Alzh...

2021-06-10

#Phispers by PHARMACOMPASS

#Blog

WHO announces new naming system for COVID variants; FDA seeks US$ 6.5 billion from Biden’s first budget

This week, we have lots of updates from the US Food and Drug Administration (FDA). The agency is seeking US$ 6.5 billion in funding under President Joe Biden’s US$ 6 trillion FY2022 budget proposal announced last week. It will use th...

2021-06-03

#Phispers by PHARMACOMPASS

#Blog

Europe eases travel restrictions; Pfizer, Astra’s vaccines show efficacy against B.1.617.2 (Indian) strain

Last week, the world of pharmaceuticals continued to be dominated by pandemic-related news. In the US, the FDA granted an emergency use authorization (EUA) to GSK and Vir Biotechnology’s antibody treatment. However, the agency said for the rema...

2021-05-27

#Phispers by PHARMACOMPASS

Blog: All Pharma Articles

#Phispers - PharmaCompass' Weekly News Recap of key industry developments so that users can quickly update themselves to be in the know.

#PharmaFlow - PharmaCompass' Data Compilation of Major Pharma & Biotech Deals. We offer Free Excel Compilations for users to perform their own analysis.

#SpeakPharma - PharmaCompass' Q&A where we follow fast-growing, innovative companies and profile them to make our users aware about new innovative capabilities and developments.

#RadioData - PharmaCompass' Data Compilations of Product & Company Sales, Non Compliances, New Drug Launches, FDA Facility Registrations, Medicare Sales Data etc. We offer Free Excel Compilations for users to perform their own analysis.

Access
Interactive
Dashboards

Access
All Data

Find

Blog & Analysis #Phispers #PharmaFlow

Hyaluronic acid – latest developments in a booming market

India reports steep rise in API prices; US$ 26 billion settlement announced to resolve opioid lawsuits

Phillip Morris acquires two drug firms; Pfizer, WHO remain at loggerheads over booster shots

GSK hits back at Elliot, supports CEO; Israel says Pfizer jab only 64% effective against delta variant

Pfizer, CDC differ on need for vaccine booster shots; FDA warning letter to Lupin reveals repeat violations

GSK CEO under pressure, to demerge consumer arm by mid-2022; Biden drops plans to donate Astra vaccine

Lupin receives FDA warning letter for Somerset plant; Delta variant may become dominant in US

Biden announces plan to make crucial drugs in US; FDA gives controversial nod to Biogen’s Alzheimer’s drug

WHO announces new naming system for COVID variants; FDA seeks US$ 6.5 billion from Biden’s first budget

Europe eases travel restrictions; Pfizer, Astra’s vaccines show efficacy against B.1.617.2 (Indian) strain

Blog: All Pharma Articles

What are you looking for?

Find

Blog: All Pharma Articles

Most Read

What are you looking for?